VTGN: Vistagen Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 127.02
Enterprise Value ($M) 0.46
Book Value ($M) 123.28
Book Value / Share 4.56
Price / Book 1.03
NCAV ($M) 120.33
NCAV / Share 4.45
Price / NCAV 1.06

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -1.52
Return on Equity (ROE) -2.65

Liquidity (mrq)
Quick Ratio 30.76
Current Ratio 30.76

Balance Sheet (mrq) ($M)
Current Assets 128.11
Assets 131.07
Liabilities 7.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Great Point Partners Llc 9.99 0.00
02-14 13G Nantahala Capital Management, LLC 5.10
02-14 13G/A Point72 Asset Management, L.P. 3.00 -47.48
02-14 13G/A Citadel Advisors Llc 5.80
02-13 13G Vanguard Group Inc 6.79
10-16 13G TCG Crossover GP II, LLC 9.90
10-16 13G Biotechnology Value Fund L P 9.99
10-06 13G/A Commodore Capital Lp 9.90 50.34
07-07 13G/A BlackRock Inc. 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q
2023-06-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 33,908 138,733 24.44
2024-04-18 36,839 71,154 51.77
2024-04-17 35,619 116,230 30.65
2024-04-16 54,468 180,739 30.14
2024-04-15 66,057 274,505 24.06

(click for more detail)

Similar Companies
VKTX – Viking Therapeutics, Inc. VRPX – Virpax Pharmaceuticals, Inc.
VSTM – Verastem, Inc. VTVT – vTv Therapeutics Inc.
VXRT – Vaxart, Inc.


Financial data and stock pages provided by
Fintel.io